Source / episode info
- **Episode:**80
- **Title:**Divine Intervention Episode 80 -USMLE Step 1 Hematology Part 2
- **Published:**2019-02-15
- Source:Episode page
One-liner
Episode 80 provides a deep dive into advanced hematology, covering the nuances of primary vs secondary hemostasis (platelet disorders, vWF), differentiating megaloblastic anemias (B12/Folate deficiency), understanding thrombotic microangiopathies (TTP/HUS), and reviewing bone marrow pathology.
High-yield summary
- Coagulation: Primary hemostasis involves platelets and vWF; secondary hemostasis relies on the intrinsic/extrinsic pathways, requiring factors like Factor VIII, IX, XI, XII, etc.
- Anemia Differentiation: Iron deficiency is characterized by microcytic, hypochromic anemia with low ferritin; B12 deficiency causes megaloblastic changes due to impaired DNA synthesis and requires parenteral replacement.
- Thrombotic Microangiopathies (TMA): TTP presents with the classic pentad (thrombocytopenia, microangiopathic hemolytic anemia [MAHA], renal failure, neurological symptoms, fever) and is often associated with ADAMTS13 deficiency; HUS typically follows nephritides/GI bleeding.
- Bone Marrow: Pancytopenia suggests marrow failure or infiltration; the differential diagnosis must consider nutritional deficiencies (B12/Folate), aplastic anemia, or malignancy.
- Bleeding Workup: A prolonged PT points to extrinsic pathway issues (Warfarin); a prolonged aPTT points to intrinsic pathway issues (Heparin/Factor deficiency).
Learning objectives
- Differentiate between primary hemostasis defects (platelet count vs function) and secondary hemostasis defects (factor deficiencies).
- Correctly diagnose the cause of megaloblastic anemia (B12 vs Folate deficiency) and determine appropriate replacement therapy routes.
- Apply knowledge of thrombotic microangiopathies, distinguishing TTP from HUS based on clinical presentation and ADAMTS13 levels.
- Understand the mechanism and management implications of common bleeding disorders like hemophilia or vWD.
- Interpret bone marrow findings (e.g., dysplasia, fibrosis) to narrow the differential diagnosis between aplastic anemia and myelodysplastic syndromes.
Board exam buzzwords